))
Medical Cannabis Goes Global - Michael Sassano of SOMAÍ reflects on UK launch - GC S2E7
Manage episode 420733739 series 3496434
Content provided by Grow Conversations. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Grow Conversations or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
SOMAÍ Pharmaceuticals is a leading EU-GMP European pharmaceutical and biotech company with a global footprint of distribution for the largest and most advanced EU GMP-certified cannabinoid-containing pharmaceuticals portfolio.
SOMAÍ owns a state-of-the-art manufacturing facility and indoor cultivation in Lisbon, Portugal, and has global sales teams in the largest medical cannabis markets.
SOMAÍ recently announced partnerships with Grow Pharma for UK distribution of the most differentiated cannabinoid-containing product portfolio, with the first product line launching in May 2024: https://www.einpresswire.com/article/...
Find out more about SOMAÍ at https://somaipharma.eu/
Discussing a range of topics including:
• Michaels background setting up medical cannabis cultivation facilities in the US. • The SOMAÍ product pipeline
• Medical vs recreational cannabis - the CEO's perspective.
• Developments n German and USA cannabis legislation.
• The nuanced differences between different medical cannabis markets internationally (UK, Germany, Australia and North America).
...and much much more.
-----------------------------------------------------------------------------------------------------
Grow Conversations is your window into the world of medical cannabis.
Brought to you by Grow Pharma - Unlocking the Medical Potential of Cannabis
Grow Pharma's Links: https://linktr.ee/grow_pharma
Grow Group's Links: https://growgroup.komi.io/
Follow Alex: https://linktr.ee/alexfrasercan...
17 episodes
Share
